30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

ARTEBONE Patent Application Accepted in Canada -

BBS-Bioactive Bone Substitutes' patent application regarding a bone protein preparation has been accepted in Canada. The patent has been valid in European and Eurasian regions for three years. The patent protects BBS' ARTEBONE® bone substitute based on tricalcium phosphate and bone proteins. It is primarily used to treat bone defects in extremities such as foot and ankle. In the future, ARTEBONE may be expanded for indications in the tibia and spine. (BBS-Bioactive Bone Substitutes Plc, 10/22/19)